News|Articles|January 1, 2003
- Pharmaceutical Technology-01-01-2003
- Volume 27
- Issue 1
Outsourcing Outlook
Author(s)Jim Miller
Developments in 2002 such as acquisitions, excess manufacturing capacity, and less funding for biotechnology will continue to affect the industry long into the new year.
Advertisement
Articles in this issue
almost 23 years ago
Pharmaceutical Pricing and Innovation Key Issues for 2003almost 23 years ago
Procedures: Improving Their Qualityalmost 23 years ago
Drug-Carrier Screening on a Chipalmost 23 years ago
Pack EXPO International 2002 Proves Worth the Tripalmost 23 years ago
Analysis of the Indian Pharmaceutical IndustryNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Audits, Inspections, and CDMOs
2
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
3
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two
4
Ready or Not: Biopharma Alignment for CNPV’s Rapid Review
5
